Euro-GASP external quality assessment (EQA) scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing 2016
An EQA scheme for antimicrobial susceptibility testing of Neisseria gonorrhoeae has been available to laboratories participating in ECDC’s European Sexually Transmitted Infections (STI) surveillance network since 2010. This is the second report to be published on the European N. gonorrhoeae EQA and has shown high levels of inter-laboratory comparability in the presence of differing methodologies across 25 countries. Overall concordance increased for most antimicrobials, except for azithromycin where the overall concordance decreased to the lowest level yet recorded.
Response plan to control and manage the threat of multi- and extensively drug-resistant gonorrhoea in Europe
7 Oct 2019 - ECDC reviewed the response plan and the 2019 update strives to further support EU Member States to develop and implement national strategies and interventions to control the threat of multidrug-resistant and extensively drug-resistant gonorrhoea in a multidisciplinary approach by outlining the suggested public health response to this threat with several vital components.
Developing a national strategy for the prevention and control of sexually transmitted infections
4 Sep 2019 - This report outlines suggested steps to develop, implement and coordinate a national STI strategy and action plan. It includes approaches to ensure the necessary stakeholder engagement for such strategies to succeed.
Euro-GASP external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing
3 Sep 2019 - External quality assessment (EQA) is an essential part of any laboratory-based surveillance system, allowing for the monitoring of performance and comparability of results from participating laboratories, identification of potential issues, and deployment of resources and training where necessary.